Viridian Therapeutics, Inc. (VRDN)
24.18
+0.16
(+0.67%)
USD |
NASDAQ |
Aug 25, 16:00
24.18
0.00 (0.00%)
After-Hours: 19:59
Viridian Therapeutics 1 Year Total Returns (Daily) : 30.21% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 30.21% |
| August 24, 2026 | 24.94% |
| August 21, 2026 | 34.79% |
| August 20, 2026 | 35.06% |
| August 19, 2026 | 39.25% |
| August 18, 2026 | 32.14% |
| August 17, 2026 | 24.54% |
| August 14, 2026 | 19.74% |
| August 13, 2026 | 16.66% |
| August 12, 2026 | 27.32% |
| August 11, 2026 | 36.00% |
| August 10, 2026 | 40.52% |
| August 07, 2026 | 42.71% |
| August 06, 2026 | 30.87% |
| August 05, 2026 | 20.81% |
| August 04, 2026 | 23.61% |
| August 03, 2026 | 10.91% |
| July 31, 2026 | 7.99% |
| July 30, 2026 | 11.80% |
| July 29, 2026 | 18.40% |
| July 28, 2026 | 13.04% |
| July 27, 2026 | 14.00% |
| July 24, 2026 | 10.18% |
| July 23, 2026 | 7.30% |
| July 22, 2026 | 13.03% |
| Date | Value |
|---|---|
| July 21, 2026 | 14.23% |
| July 20, 2026 | 12.35% |
| July 17, 2026 | 5.75% |
| July 16, 2026 | 7.39% |
| July 15, 2026 | 17.22% |
| July 14, 2026 | 11.32% |
| July 13, 2026 | 11.44% |
| July 10, 2026 | 15.24% |
| July 09, 2026 | 18.54% |
| July 08, 2026 | 23.74% |
| July 07, 2026 | 28.82% |
| July 06, 2026 | 21.19% |
| July 02, 2026 | 27.38% |
| July 01, 2026 | 27.71% |
| June 30, 2026 | 31.40% |
| June 29, 2026 | 31.12% |
| June 26, 2026 | 23.02% |
| June 25, 2026 | 18.30% |
| June 24, 2026 | 18.14% |
| June 23, 2026 | 17.47% |
| June 22, 2026 | 19.77% |
| June 18, 2026 | 10.87% |
| June 17, 2026 | 12.64% |
| June 16, 2026 | 0.25% |
| June 15, 2026 | 2.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.73% |
| Alnylam Pharmaceuticals, Inc. | -45.88% |
| Anika Therapeutics, Inc. | 134.4% |
| Savara, Inc. | 78.34% |
| Vericel Corp. | 20.76% |